Outcomes of a Contemporary Sample of Patients With Atrial Fibrillation Taking Digoxin: Results From the AFBAR Study

Revista Espanola de Cardiologia - Tập 67 - Trang 890-897 - 2014
Moisés Rodríguez-Mañero1, Fernando Otero-Raviña2, Javier García-Seara1, Lucrecia Zugaza-Gurruchaga3, José M. Rodríguez-García4, Rubén Blanco-Rodríguez5, Victorino Turrado Turrado6, José M. Fernández-Villaverde7, Rafael C. Vidal-Pérez1, José R. González-Juanatey1
1Servizo de Cardioloxía, Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), SERGAS, Santiago de Compostela, A Coruña, Spain
2Dirección de Asistencia Sanitaria, SERGAS, Santiago de Compostela, A Coruña, Spain
3Centro de Saúde de Negreira, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Negreira, A Coruña, Spain
4Centro de Saúde de A Pobra do Caramiñal, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, A Pobra do Caramiñal, A Coruña, Spain
5Centro de Saúde de Lousame, Xerencia de Xestión Integrada Santiago de Compostela, SERGAS, Lousame, A Coruña, Spain
6Centro de Saúde Concepción Arenal, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Santiago de Compostela, A Coruña, Spain
7Centro de Saúde de Ribeira, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Ribeira, A Coruña, Spain

Tài liệu tham khảo

Withering, 1941, An account of the foxglove and some of its medical uses with practical remarks on dropsy and other diseases, 231

Gheorghiade, 2006, Contemporary use of digoxin in the management of cardiovascular disorders, Circulation, 113, 2556, 10.1161/CIRCULATIONAHA.105.560110

Eichhorn, 2002, Digoxin-new perspective on an old drug, N Engl J Med, 347, 1394, 10.1056/NEJMp020118

Friberg, 2010, Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF), Heart, 96, 275, 10.1136/hrt.2009.175786

Abu-Assi, 2011, Comparison of the reliability and validity of four contemporary risk stratification schemes to predict thromboembolism in non-anticoagulated patients with atrial fibrillation, Int J Cardiol, 19, 349

Martí-Almor, 2013, Tratamiento antiarrítmico farmacológico en fase crónica de la fibrilación auricular, Rev Esp Cardiol Supl, 13, 21

Alfonso Martín, 2013, Tratamiento agudo de la fibrilación auricular en urgencias, Rev Esp Cardiol Supl, 13, 14

García-Castelo, 2011, Prognostic impact of atrial fibrillation progression in a community study: AFBAR Study (Atrial Fibrillation in the Barbanza Area Study), Int J Cardiol, 153, 68, 10.1016/j.ijcard.2010.08.042

Hallberg, 2007, Digoxin and mortality in atrial fibrillation: a prospective cohort study, Eur J Clin Pharmacol, 63, 1201, 10.1007/s00228-007-0346-9

Whitbeck, 2012, Increased mortality among patients taking digoxin-analysis from the AFFIRM study, Eur Heart J, 27, 1

Wyse, 2002, A comparison of rate control and rhythm control in patients with atrial fibrillation, N Engl J Med, 347, 1825, 10.1056/NEJMoa021328

Murphy, 2013, When ‘digoxin use’ is not the same as ‘digoxin use’: lessons from the AFFIRM trial, Eur Heart J, 34, 1465, 10.1093/eurheartj/eht087

Van Gelder, 2010, Lenient versus strict rate control in patients with atrial fibrillation, N Engl J Med, 362, 1363, 10.1056/NEJMoa1001337

Uretsky, 1993, Randomized study assessing the effect of digoxin withdrawal inpatients with mild to moderate chronic congestive heart failure: results of the PROVED trial, J Am Coll Cardiol, 22, 955, 10.1016/0735-1097(93)90403-N

Packer, 1993, Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study, N Engl J Med, 329, 1, 10.1056/NEJM199307013290101

1988, Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure, JAMA, 259, 539, 10.1001/jama.1988.03720040031022

Di Bianco, 1989, A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure, N Engl J Med, 320, 677, 10.1056/NEJM198903163201101

1988, Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure, Lancet, 1, 489

Guyatt, 1988, A controlled trial of digoxin in congestive heart failure, Am J Cardiol, 61, 371, 10.1016/0002-9149(88)90947-2

1997, The effect of digoxin on mortality and morbidity in patients with heart failure, N Engl J Med, 336, 525, 10.1056/NEJM199702203360801

Dhaliwal, 2008, Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy, Am J Cardiol, 102, 1356, 10.1016/j.amjcard.2008.07.014

Rathmore, 2002, Sex-based differences in the effect of digoxin for the treatment of heart failure, N Engl J Med, 347, 1403, 10.1056/NEJMoa021266

Flory, 2012, Observational cohort study of the safety of digoxin use in women with heart failure, BMJ Open, 2, e000888, 10.1136/bmjopen-2012-000888

Domanski, 2005, The effect of gender on outcome in digitalis-treated heart failure patients, J Card Fail, 11, 83, 10.1016/j.cardfail.2004.07.002

Thông tin
Thông tin xuất bản

Revista Espanola de Cardiologia

Tập 67

890-897

Thông tin tác giả